SCHEMBL22751698

SCHEMBL22751698

Cc1ccc2c(c1)Oc1cc(C)ccc1N2c1cc2c3ccccc3n3c4ccccc4c(c1)c23

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ KIF11 P52732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22751637 0.86 — —
SCHEMBL22751700 0.84 P2RX4 (0.33) MAPTHTT
SCHEMBL22751661 0.83 — —
SCHEMBL22751640 0.83 MAPT (0.36) BCHEACHELMNAMAPTHTT
SCHEMBL22751633 0.81 DRD3 (0.35) BCHEACHELMNAMAPTHTT
SCHEMBL22751659 0.80 BCHE (0.30) BCHEACHELMNAMAPTHTT
SCHEMBL22751638 0.80 PKM (0.34) MAPT
SCHEMBL22751639 0.79 PDK2 (0.34) —
SCHEMBL20689998 0.79 KDM4E (0.31) —
SCHEMBL22751645 0.76 KMT2A (0.33) LMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10862050-B2 Heterocyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10862050-B2 Heterocyclic compound and organic electroluminescence device including the same CCNT1, CCNL2, CCNA1 BCHE 4177/4885ACHE 1746/4885LMNA 2930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback